Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer
2017 ◽
Vol 41
(5)
◽
pp. 731-736
◽
2012 ◽
Vol 188
(5)
◽
pp. 1732-1738
◽
2015 ◽
Vol 18
(3)
◽
pp. 221-228
◽